IZAFE-BiZafe Group AB (publ)
0.3390SEK-0.88%Mkt Cap: 140.27M SEKP/E: Last update: 2026-05-13

iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automa…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)
PEG
P/B5.75
P/S19.78
EV/EBITDA-7.75
EV/Revenue18.80
EPS (TTM)-0.06
EPS (Forward)
Cash Flow & Leverage
FCF Yield0.53%
FCF Margin10.43%
Operating CF-14.56M SEK
CapEx (TTM)
Net Debt/EBITDA0.40
Net Debt-6.93M SEK
Technical
SMA 500.3901 (-13.1%)
SMA 2000.4722 (-28.2%)
Beta-0.06
S&P 52W Chg24.23%
Avg Vol (30d)788.70K
Avg Vol (10d)747.95K
Technical Indicators
RSI (14)32.5
MACD-0.0154
MACD Signal-0.0118
MACD Hist.-0.0036
BB Upper0.4178 SEK
BB Middle0.3754 SEK
BB Lower0.3329 SEK
BB Width22.59%
ATR (14)0.0300 SEK
Vol Ratio (20d)0.18x
52W Range
0.230019% of range0.8000
52W High0.8000 SEK
52W Low0.2300 SEK
Profitability
Gross Margin40.13%
EBITDA Margin-242.55%
Profit Margin-278.35%
Oper. Margin-242.79%
ROE-142.71%
ROA-46.80%
Revenue Growth83.50%
Earnings Growth
Balance Sheet
Debt/Equity0.01
Current Ratio0.99
Quick Ratio0.81
Book Value/Sh0.0600 SEK
Cash/Share0.0180 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split11:10
Split DateDec 7, 2011
Ownership
Shares Out.405.99M
Float397.62M
Insiders0.00%
Institutions1.42%
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Company
Market Cap140.27M SEK
Enterprise Value133.35M SEK
Revenue (TTM)7.09M SEK
Gross Profit2.40M SEK
Net Income (TTM)-16.68M SEK
Revenue/Share0.0200 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
Last Price0.3390 SEK
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN